SPY362.06-1.61 -0.44%
DIA296.62-2.62 -0.88%
IXIC12,198.74-7.11 -0.06%

Vascular Biogenics Q3 EPS $(0.12) Beats $(0.13) Estimate, Sales $193.00K Beat $170.00K Estimate

Vascular Biogenics (NASDAQ:VBLT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 14.29 percent increase over losses of $(0.14) per share from

· 11/16/2020 07:05
Vascular Biogenics (NASDAQ:VBLT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 14.29 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $193.00 thousand which beat the analyst consensus estimate of $170.00 thousand by 13.53 percent. This is a 144.30 percent increase over sales of $79.00 thousand the same period last year.